# Augmedix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/augmedix

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.augmedix.com
- Total disclosed funding: $78M
- Latest round: Series B (Oct 24, 2019)
- Investors on record: 15

## About

Based in California, US, and founded in 2012 by Ian Shakil and Pelu Tran, Augmedix, Inc. a Commure company operates as a telemedicine charting service provider that offers a physician productivity platform designed to convert natural clinical-patient conversation into medical documentation. The company trades in OTCQX under the ticker symbol AUGX. In July 2024, Commure, Inc., a portfolio company of Sequoia Capital Global Equities, General Catalyst Partners, Shasta Ventures, Greenoaks Capital, Y Combinator, Initialized Capital, Liquid 2 Ventures, FJ Labs, Fifty Years, Tribe Capital, Human Capital, agreed to acquire Augmedix, Inc. for approximately USD 139 million. The transaction was completed in October 2024. Augmedix, Inc. provides a digital platform that is compatible with off-the-shelf, mobile client devices that enables clinicians to communicate with remotely located documentation specialists (RDSs). In addition, the company offers various services, including Augmedix Live and Augmedix Notes. Augmedix Live is a real-time service that RDSs provide medical documentation and live clinical support services. Augmedix Notes is a non-real-time product where RDSs offer medical documentation based upon recorded visits.The July 2024 acquisition aims to support the development of the company's health AI operating system.

## Funding rounds

- Series B, Oct 24, 2019, $19M — DCM, Redmile Group, McKesson Ventures, Gaingels, Wanxiang Healthcare Investments
- Series A, Oct 21, 2016, $23M — OrbiMed Advisors, DCM, Emergence Capital, Redmile Group, Great Oaks Venture Capital, McKesson Ventures, StartX
- Series A, Oct 6, 2015, $17M — DCM, Emergence Capital, Dignity Health, Redmile Group, Catholic Health Initiatives Operating Investment Program, Sutter Health, TriHealth, Inc.
- Series A, Dec 23, 2014, $16M — DCM, Emergence Capital
- Seed, Jun 5, 2013 — Rock Health
- Seed, Apr 30, 2013, $3.2M — DCM, Emergence Capital, Great Oaks Venture Capital, Lifeforce Ventures, LLC

## Investors

- DCM (https://capitalatlas.ai/funds/dcm) — Seed, Series A, Series B
- Emergence Capital (https://capitalatlas.ai/funds/emergence-capital) — Seed, Series A
- Great Oaks Venture Capital (https://capitalatlas.ai/funds/great-oaks-venture-capital) — Seed, Series A
- Lifeforce Ventures, LLC — Seed
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed
- Dignity Health — Series A
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A, Series B
- Catholic Health Initiatives Operating Investment Program (https://capitalatlas.ai/funds/catholic-health-initiatives-operating-investment-program) — Series A
- Sutter Health — Series A
- TriHealth, Inc. — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series A, Series B
- StartX — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B
- Wanxiang Healthcare Investments (https://capitalatlas.ai/funds/wanxiang-healthcare-investments) — Series B